Galapagos | GLPG - Ebit

Preço das Ações
27.68
Mudança Diária
-0.38 -1.35%
Mensal
-2.54%
Anual
14.76%
Q1 Previsão
27.05




Ebit Alterar Data
argenx SE USD 371.14M 21.17M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Biogen USD 659.6M 157M 2025-09
Genmab DKK 260M 199M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
GRIFOLS EUR 352.11M 20.18M 2025-09
Hikma Pharmaceutical USD 348M 31M 2025-12
Incyte USD 383.88M 47.44M 2025-12
Merck EUR 474M 738M 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Novartis USD 4.06B 530M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
UCB EUR 1.29B 571M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12